M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_22853

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_22853 33 0.70 Mlig455_019405, Mlig455_059068

Neo: -

Age: -

Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811}

Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811}

Cumulative graph for MligTC455_22853

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -1.181 1.253 1.00000 1.00000
RegionR2 1.582 1.253 0.31133 0.70218
RegionR3 2.662 1.253 0.04334 0.36369
RegionR4 2.416 1.253 0.16077 0.41832
RegionR5 2.331 1.253 0.05483 0.20007
RegionR6 -2.775 1.253 1.00000 1.00000
RegionR7 -2.444 1.253 1.00000 1.00000
RegionR8 -2.591 1.253 1.00000 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 1.719 1.253 0.99993 1.00000
RegenerationR2 1.65 1.253 0.18259 0.62564
RegenerationR3 0.911 1.253 0.47352 0.84608
RegenerationR4 0.125 1.253 0.92290 1.00000
RegenerationR5 0.115 1.253 0.85527 1.00000
RegenerationR6 5.441 1.253 0.00640 0.09774
RegenerationBL 2.069 1.253 0.99983 1.00000
RegenerationTP 4.761 1.253 0.09264 0.47795


Genes with expression patterns similar to MligTC455_22853

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_22853 33 0.7 Mlig455_019405, Mlig455_059068

Neo: -

Age: -

 5 1.000 1.000 - 1.000 1.000 1.000

Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811}

Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811}
2. MligTC455_12203 8 0.17 Mlig455_061049

Neo: -

Age: -

 1.707 - - - - 0.976 0.731 Mlig455_061049 {REF} {Length: 1492} {RNA1509_16662} {RNA1310_122445} {RNA815_4833.1}
3. MligTC455_22627 74 1.53 Mlig455_012518

Neo: -

Age: -

 CAPZB 1.695 - - - 0.951 - 0.744 Mlig455_012518 {REF} {Length: 1637} {TRANSSPLICED} {Pfam: F-actin capping protein, beta subunit [PF01115.19, score=272.4]} {Human: ENSG00000077549, CAPZB, capping actin protein of muscle Z-line subunit beta, [Score=275, Expect=7e-92]} {Mouse: ENSMUSG00000028745, Capzb, capping protein (actin filament) muscle Z-line, beta, [Score=275, Expect=5e-92]} {Dmel: FBgn0011570, cpb, capping protein beta, [Score=268, Expect=1e-89]} {Celegans: WBGene00000293, cap-2, F-actin-capping protein subunit beta, [Score=249, Expect=4e-82]} {Smed: dd_Smed_v6_1165_0_1, dd_Smed_v6_1165_0_1, [Score=283, Expect=1e-95]} {RNA1509_26511} {RNA1310_18322.1} {RNA815_12071}
4. MligTC455_35325 26 0.54 Mlig455_008452, Mlig455_031353, Mlig455_056519

Neo: -

Age: -

 HTR3A 0.998 - - - - 0.998 -

Mlig455_008452 {REF} {Length: 1552} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010}

Mlig455_031353 {REF} {Length: 1802} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=61.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=54.4]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=103, Expect=5e-25]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=101, Expect=1e-24]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=100, Expect=4e-24]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=98.2, Expect=2e-23]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=96.3, Expect=7e-23]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=93.6, Expect=6e-22]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=90.5, Expect=5e-21]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010}

Mlig455_056519 {REF} {Length: 1867} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_53098} {RNA1310_93708} {RNA815_49010}
5. MligTC455_50029 35 0.74 Mlig455_010619, Mlig455_010708

Neo: -

Age: -

 FOXA1 0.998 - - - - 0.998 -

Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]}

Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]}
6. MligTC455_23922 8 0.17 Mlig455_001765

Neo: -

Age: Down-Up-Down

 0.993 - - - - 0.993 - Mlig455_001765 {REF} {Length: 4721} {Pfam: AMP-binding enzyme [PF00501.30, score=68.9]} {RNA1509_37800} {RNA1310_40483} {RNA815_30709}
7. MligTC455_53285 6 0.13 Mlig455_061305

Neo: -

Age: -

 0.988 - - - - 0.988 - Mlig455_061305 {REF} {Length: 422} {NoTransDecoderORF}
8. MligTC455_31212 97 2.02 Mlig455_028599, Mlig455_056911

Neo: -

Age: -

 0.987 - - - - 0.987 -

Mlig455_028599 {REF} {Length: 600} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362}

Mlig455_056911 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362}
9. MligTC455_05979 11 0.23 Mlig455_067718

Neo: -

Age: -

 0.981 - - - - 0.981 - Mlig455_067718 {REF} {Length: 1018} {RNA1509_2330} {RNA1310_37520} {RNA815_22367}
10. MligTC455_33875 32 0.67 Mlig455_039631

Neo: -

Age: -

 0.981 - - - - 0.981 - Mlig455_039631 {REF} {Length: 3055} {TRANSSPLICED} {RNA1509_14655, RNA1509_53977} {RNA1310_22046.1, RNA1509_53977} {RNA1509_53977, RNA815_8738}
11. MligTC455_49259 69 1.44 Mlig455_022552

Neo: -

Age: -

 0.981 - - - - - 0.981 Mlig455_022552 {REF} {Length: 742} {RNA1310_65296} {RNA815_34444}
12. MligTC455_06577 7 0.14 Mlig455_044334

Neo: -

Age: Up-Down-Down

 0.98 - - - - 0.980 - Mlig455_044334 {REF} {Length: 706}
13. MligTC455_31210 51 1.07 Mlig455_028581

Neo: -

Age: Down-Up-Down

 KCNH7 0.98 - - - - 0.980 - Mlig455_028581 {REF} {Length: 6310} {Pfam: Ion transport protein [PF00520.33, score=119.1]; PAS domain [PF13426.9, score=52.9]; Ion channel [PF07885.18, score=45.3]; Cyclic nucleotide-binding domain [PF00027.31, score=45.2]; PAS fold [PF00989.27, score=31.5]; PAS fold [PF08447.14, score=26.5]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=820, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=810, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=808, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=820, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=808, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=806, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=746, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=793, Expect=0.0]} {RNA1509_40124} {RNA1310_20497} {RNA815_15478}
14. MligTC455_02461 5 0.11 Mlig455_019900

Neo: -

Age: -

 0.978 - - - - 0.978 - Mlig455_019900 {REF} {Length: 253} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135}
15. MligTC455_51200 66 1.37 Mlig455_057090

Neo: -

Age: -

 0.978 - - - - 0.978 - Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272}
16. MligTC455_14578 33 0.69 Mlig455_033066

Neo: -

Age: -

 0.977 - - - - 0.977 - Mlig455_033066 {REF} {Length: 2292} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.2]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=63.9, Expect=1e-10]} {RNA1310_28762} {RNA815_42177}
17. MligTC455_25410 47 0.97 Mlig455_026185

Neo: -

Age: Up-Down-Down

Region-enriched R2: 8.036/0.00469
Region-enriched R6: 6.422/0.01487

 0.977 - - - - 0.977 - Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868}
18. MligTC455_10605 2 0.04 Mlig455_047968

Neo: -

Age: -

 0.976 - - - - 0.976 - Mlig455_047968 {REF} {Length: 297} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} {RNA815_25886}
19. MligTC455_14604 21 0.43 Mlig455_014269

Neo: -

Age: -

 0.976 - - - - 0.976 - Mlig455_014269 {REF} {Length: 2720} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=90.5]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=108, Expect=3e-25]} {RNA1310_19428.1} {RNA815_22602}
20. MligTC455_19126 10 0.2 Mlig455_009225

Neo: -

Age: -

 0.976 - - - - 0.976 - Mlig455_009225 {REF} {Length: 1570} {Pfam: Galactosyltransferase [PF01762.23, score=21.4]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=50.4, Expect=1e-06]} {RNA1310_57689} {RNA815_57743}
21. MligTC455_55494 2 0.05 Mlig455_004790

Neo: -

Age: -

 0.976 - - - - 0.976 - Mlig455_004790 {REF} {Length: 600} {Pfam: Receptor family ligand binding region [PF01094.30, score=64.3]; Periplasmic binding protein [PF13458.8, score=19.1]}
22. MligTC455_19225 26 0.54 Mlig455_018507

Neo: -

Age: -

 SCNN1B 0.974 - - - - 0.974 - Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764}
23. MligTC455_30594 23 0.48 Mlig455_038529, Mlig455_052221

Neo: -

Age: -

 0.974 - - - - 0.974 -

Mlig455_038529 {REF} {Length: 805} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=35.1]} {RNA1509_40834} {RNA1310_11051} {RNA815_3523.1}

Mlig455_052221 {REF} {Length: 7356} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=40.2]; Mab-21 protein [PF03281.16, score=18.9]} {RNA1509_14346, RNA1509_40834} {RNA1310_11051, RNA1509_14346} {RNA1509_14346, RNA815_3523.1}
24. MligTC455_53286 6 0.13 Mlig455_061308

Neo: -

Age: -

 0.974 - - - - 0.974 - Mlig455_061308 {REF} {Length: 398} {NoTransDecoderORF}
25. MligTC455_54226 52 1.09 Mlig455_037435, Mlig455_037458

Neo: -

Age: -

 NETO2 0.974 - - - - 0.974 -

Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111}

Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111}
26. MligTC455_00622 2 0.05 Mlig455_047108

Neo: -

Age: -

 0.973 - - - - 0.973 - Mlig455_047108 {REF} {Length: 64} {NoTransDecoderORF}
27. MligTC455_09686 4 0.08 Mlig455_061629

Neo: -

Age: -

 0.973 - - - - 0.973 - Mlig455_061629 {REF} {Length: 1698} {NoTransDecoderORF} {RNA1509_20320} {RNA1310_104302} {RNA815_52785.1}
28. MligTC455_49214 6 0.13 Mlig455_068565

Neo: -

Age: -

 0.973 - - - - 0.973 - Mlig455_068565 {REF} {Length: 1544} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=105.5]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=53.1, Expect=3e-08]} {RNA1310_27155} {RNA815_39321}
29. MligTC455_42708 48 1.01 Mlig455_027999, Mlig455_028026

Neo: -

Age: -

 0.967 - - - - 0.967 -

Mlig455_027999 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552}

Mlig455_028026 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552}
30. MligTC455_00072 10 0.2 Mlig455_001911

Neo: -

Age: -

 0.966 - - - - 0.966 - Mlig455_001911 {REF} {Length: 296} {NoTransDecoderORF} {RNA1310_118235}
31. MligTC455_44444 123 2.57 Mlig455_062758

Neo: -

Age: -

 0.965 - - - - 0.965 - Mlig455_062758 {REF} {Length: 1304} {Pfam: Retinal tissue protein [PF10044.11, score=28.1]} {RNA1509_3524} {RNA1310_10649.1} {RNA815_4708.1}
32. MligTC455_15005 13 0.26 Mlig455_007503

Neo: -

Age: -

 0.964 - - - - 0.964 - Mlig455_007503 {REF} {Length: 2488} {Pfam: Immunoglobulin domain [PF13895.8, score=20.5]} {RNA1310_66411} {RNA815_43821}
33. MligTC455_31082 93 1.93 Mlig455_020193

Neo: -

Age: Up-Down-Up

 0.963 - - - - 0.963 - Mlig455_020193 {REF} {Length: 1952} {RNA1509_54750} {RNA1310_22843} {RNA815_11564.1}
34. MligTC455_43753 82 1.71 Mlig455_018087

Neo: -

Age: -

 0.96 - - - - 0.960 - Mlig455_018087 {REF} {Length: 2050} {RNA1509_20267} {RNA1310_4680} {RNA815_3273}
35. MligTC455_09822 5 0.1 Mlig455_017858

Neo: -

Age: -

 0.959 - - - - 0.959 - Mlig455_017858 {REF} {Length: 616} {NoTransDecoderORF} {RNA1310_73710}
36. MligTC455_47574 716 14.92 Mlig455_028318, Mlig455_066192

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=1.060

Region-enriched R2: 1.667/0.01738

 MAN1C1 0.959 - - - - 0.959 -

Mlig455_028318 {REF} {Length: 2839} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_9530} {RNA1310_9474.1} {RNA815_6962}

Mlig455_066192 {REF} {Length: 2836} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_53617, RNA1509_9530} {RNA1310_9474.1, RNA1509_53617} {RNA1509_53617, RNA815_6962}
37. MligTC455_15053 12 0.26 Mlig455_016326

Neo: -

Age: -

 0.957 - - - - 0.957 - Mlig455_016326 {REF} {Length: 2006} {NoTransDecoderORF} {RNA1509_50409, RNA1509_54815} {RNA1310_146928, RNA1509_50409} {RNA1509_50409, RNA815_32053}
38. MligTC455_33637 187 3.9 Mlig455_027211, Mlig455_027458

Neo: -

Age: -

Region-enriched R2: 3.458/0.04514

 CHRNA10, CHRNA7 0.957 - - - - 0.957 -

Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2}

Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2}
39. MligTC455_14124 9 0.19 Mlig455_004227, Mlig455_031052, Mlig455_031059

Neo: -

Age: Up-Down-Down, logFC(26M/2M)=-1.177

 OTOGL, SSPO 0.956 - - - - 0.956 -

Mlig455_004227 {REF} {Length: 8347} {Pfam: von Willebrand factor type D domain [PF00094.27, score=218.9]; C8 domain [PF08742.13, score=94.5]; Low-density lipoprotein receptor domain class A [PF00057.20, score=62.7]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=52.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=506, Expect=2e-143]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=499, Expect=2e-141]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=327, Expect=5e-89]} {Celegans: WBGene00020481, T13C2.6, [Score=107, Expect=5e-23]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1126, Expect=0.0]} {RNA1509_11979, RNA1509_44751} {RNA1310_598, RNA1509_44751} {RNA1509_44751, RNA815_582}

Mlig455_031052 {REF} {Length: 3393} {Pfam: von Willebrand factor type D domain [PF00094.27, score=117.0]; C8 domain [PF08742.13, score=60.4]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.8]} {Human: ENSG00000165899, OTOGL, otogelin like, [Score=200, Expect=1e-51]} {Mouse: ENSMUSG00000001930, Vwf, Von Willebrand factor, [Score=200, Expect=8e-52]; ENSMUSG00000091455, Otogl, otogelin-like, [Score=196, Expect=1e-50]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=149, Expect=4e-36]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=497, Expect=7e-154]} {RNA1509_47011} {RNA1310_598} {RNA815_582}

Mlig455_031059 {REF} {Length: 5292} {Pfam: von Willebrand factor type D domain [PF00094.27, score=221.4]; C8 domain [PF08742.13, score=99.8]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=55.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=52.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=489, Expect=4e-142]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=488, Expect=6e-142]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=322, Expect=1e-88]} {Celegans: WBGene00003071, lrp-1, Low-density lipoprotein receptor-related protein, [Score=74.7, Expect=6e-13]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1061, Expect=0.0]} {RNA1509_47011} {RNA1310_598} {RNA815_582}
40. MligTC455_41297 10 0.21 Mlig455_015247

Neo: -

Age: -

 0.956 - - - - 0.956 - Mlig455_015247 {REF} {Length: 738} {NoTransDecoderORF}
41. MligTC455_42103 19 0.4 Mlig455_013890

Neo: -

Age: -

 ARID3A 0.956 - - - - 0.956 - Mlig455_013890 {REF} {Length: 2772} {Pfam: ARID/BRIGHT DNA binding domain [PF01388.23, score=72.2]} {Human: ENSG00000116017, ARID3A, AT-rich interaction domain 3A, [RH, Score=244, Expect=2e-71]; ENSG00000205143, ARID3C, AT-rich interaction domain 3C, [RH, Score=242, Expect=1e-72]; ENSG00000179361, ARID3B, AT-rich interaction domain 3B, [RH, Score=233, Expect=8e-68]} {Mouse: ENSMUSG00000019564, Arid3a, AT rich interactive domain 3A (BRIGHT-like), [RH, Score=247, Expect=9e-73]; ENSMUSG00000066224, Arid3c, AT rich interactive domain 3C (BRIGHT-like), [RH, Score=245, Expect=2e-74]} {Dmel: FBgn0004795, retn, retained, [RH, Score=241, Expect=2e-68]} {Celegans: WBGene00000476, cfi-1, AT-rich interactive domain-containing protein cfi-1, [RH, Score=231, Expect=3e-68]} {Smed: dd_Smed_v6_13474_0_1, dd_Smed_v6_13474_0_1, [RH, Score=259, Expect=1e-77]} {RNA1509_54880} {RNA1310_44805} {RNA815_49768}
42. MligTC455_49875 59 1.22 Mlig455_027217

Neo: -

Age: -

 0.956 - - - - 0.956 - Mlig455_027217 {REF} {Length: 1809} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.9]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=64.7, Expect=5e-12]} {Celegans: WBGene00008997, lgc-31, Ligand-Gated ion Channel, [Score=70.9, Expect=3e-14]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=67.0, Expect=6e-13]} {RNA1310_26175} {RNA815_7952}
43. MligTC455_49878 31 0.65 Mlig455_050656

Neo: -

Age: -

 CHRNA10 0.956 - - - - 0.956 - Mlig455_050656 {REF} {Length: 1810} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.7]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=145, Expect=8e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=7e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=4e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=9e-37]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=143, Expect=9e-38]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=7e-37]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=139, Expect=4e-36]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=134, Expect=3e-34]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=126, Expect=9e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=133, Expect=3e-34]} {RNA1310_26175} {RNA815_7952}
44. MligTC455_10204 14 0.29 Mlig455_049702, Mlig455_049708

Neo: -

Age: -

 0.955 - - - - 0.955 -

Mlig455_049702 {REF} {Length: 217} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_47324} {RNA815_43123}

Mlig455_049708 {REF} {Length: 443} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_57782} {RNA815_43123}
45. MligTC455_26219 33 0.69 Mlig455_032559

Neo: Irradiation

Age: Down-Up-Down

 0.953 - - - - 0.953 - Mlig455_032559 {REF} {Length: 2476} {TRANSSPLICED} {RNA1509_38431} {RNA1310_17856.1} {RNA815_9396}
46. MligTC455_29464 25 0.53 Mlig455_021892

Neo: -

Age: -

 SDCCAG8 0.952 - - - - 0.952 - Mlig455_021892 {REF} {Length: 3036} {Pfam: Centrosomal colon cancer autoantigen protein family [PF15964.7, score=164.7]} {Human: ENSG00000276111, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]; ENSG00000054282, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000026504, Sdccag8, serologically defined colon cancer antigen 8, [RH, Score=109, Expect=4e-24]} {Dmel: FBgn0266566, CG45105, [Score=52.4, Expect=2e-06]} {Smed: dd_Smed_v6_9295_0_2, dd_Smed_v6_9295_0_2, [RH, Score=87.8, Expect=7e-18]} {RNA1509_42574} {RNA1310_5942.1} {RNA815_9353.1}
47. MligTC455_19171 162 3.38 Mlig455_047844

Neo: -

Age: -

 LRRD1 0.951 - - - - 0.951 - Mlig455_047844 {REF} {Length: 3483} {Pfam: Leucine rich repeat [PF13855.8, score=200.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=161.9]; Leucine-rich repeat [PF14580.8, score=62.9]; Death domain [PF00531.24, score=25.2]; RsmF rRNA methyltransferase first C-terminal domain [PF17126.7, score=19.3]} {Human: ENSG00000240720, LRRD1, leucine rich repeats and death domain containing 1, [RH, Score=265, Expect=2e-76]} {Mouse: ENSMUSG00000040367, Lrrd1, leucine rich repeats and death domain containing 1, [RH, Score=305, Expect=1e-91]} {Dmel: FBgn0038504, Sur-8, [Score=157, Expect=3e-40]} {Celegans: WBGene00004929, soc-2, Leucine-rich repeat protein soc-2, [Score=151, Expect=1e-38]} {Smed: dd_Smed_v6_10136_0_1, dd_Smed_v6_10136_0_1, [RH, Score=281, Expect=6e-85]} {RNA1509_11343, RNA1509_19633} {RNA1310_7039.2, RNA1509_11343} {RNA1509_11343, RNA815_1369.1}
48. MligTC455_39022 18 0.38 Mlig455_040588, Mlig455_062046, Mlig455_068792

Neo: -

Age: -

 0.951 - - - - 0.951 -

Mlig455_040588 {REF} {Length: 1473} {RNA1509_21391} {RNA1310_6366} {RNA815_11612}

Mlig455_062046 {REF} {Length: 802} {TRANSSPLICED} {RNA1509_21391} {RNA1310_6366} {RNA815_31706}

Mlig455_068792 {REF} {Length: 1535} {TRANSSPLICED} {RNA1509_21391} {RNA1310_6366} {RNA815_11612}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA